Ceptaris Secures $10 Million in Series D-1 Financing

By WebmasterJune 5, 2012November 1st, 2024No Comments

Ceptaris Secures $10 Million in Series D-1 Financing
Read more here

Previous PostTREVENTIS Corporation Scientific Founder, Named Sobey Chair in Alzheimer’s Disease Research
Next PostNiiki Pharma to Present Final Phase I Clinical Data on Anti-Cancer Agent at ASCO